SIA
GILD icon

Sovereign Investment Advisors’s Gilead Sciences GILD Stock Holding History

Sovereign Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,780
Closed -$257K – 63
2024
Q4 		$257K Buy
+2,780
New +$250K 0.08% 77

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sovereign Investment Advisors's GILD Position: Q1 2025 in Review

Sovereign Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 2,780 shares — an estimated $257K sold.

Sovereign Investment Advisors first reported a position in GILD in Q4 2024 and held it in 1 quarter. The position peaked at $257K in Q4 2024. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Sovereign Investment Advisors reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Sovereign Investment Advisors sold 2,780 Gilead Sciences shares in Q1 2025, an estimated $257K.
  • Sovereign Investment Advisors first reported a position in Gilead Sciences in Q4 2024 and held it in 1 quarter.
  • Sovereign Investment Advisors's Gilead Sciences position peaked at $257K in Q4 2024.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Sovereign Investment Advisors's 13F filing for Q1 2025, filed 8 May 2025.